Aarti Drugs Limited has officially announced that its Board of Directors is scheduled to meet on Friday, May 15, 2026. The primary objective of this meeting is to review, consider, and approve the company’s audited financial results for the fourth quarter and the full financial year ending March 31, 2026. Investors and stakeholders are awaiting the financial outcome, which will be released following the board’s formal approval.
Upcoming Board Meeting Details
The management of Aarti Drugs Limited has confirmed that a meeting of the Board of Directors will take place on May 15, 2026. This critical meeting is dedicated to finalizing the financial health of the company for the fiscal year concluded on March 31, 2026. The board will take on record the performance results for the final quarter (Q4) and the overall annual financial statements.
Trading Window Restrictions
In adherence to internal compliance protocols established on March 25, 2026, the company’s trading window remains closed. This restriction is active for designated persons and employees to maintain transparency and market integrity ahead of the announcement. The trading window is set to reopen 48 hours following the public declaration of the audited financial results.
Source: BSE
